it-ITen-US
FLUIMUCIL INFLUENZA E RAFFREDDORE

Why use it?

Learn More

It is a Paracetamol and Pseudoephedrine hydrochloride based compound for treating colds and flu.
Adults and adolescents over the age of 12: 2 to 3 times sachets a day.

Duration of therapy:
max 5 days of therapy for the adult population;
max 3 days of therapy for the pediatric population (12-18 years of age).
Fluimucil Influenza e Raffreddore is indicated for the treating of flu and paraflu symptoms such as headaches, nasal congestion, fever and joint pain.
Fluimucil Influenza e Raffreddore in granules contains: active ingredient – Paracetamol and Pseudoephedrine hydrochloride; Excipients – Saccharose, anhydride citric acid, tropical fruit flavour, grapefruit flavour, sorbitol E420, aspartame E951, sucrose, sodium saccharine, polysorbate 20, red colouring of beetroot, riboflavin sodium phosphate colouring.
Fluimucil Influenza e Raffreddore frees from flu and cold symptoms though a triple analgesic, antipyretic and decongesting function, for immediate relief without drowsiness.
Paracetamol exercises antipyretic action, reducing fever rapidly; it also has an analgesic action which eliminates head and joint pain, typical of forms of flu. Pseudoephedrine hydrochloride frees nasal mucous membranes through an action of vasoconstriction with a reduction of nasal congestion and hyper-secretion.

Interaction with other drugs

Fluimucil Influenza e Raffreddore may interact, and thus is to be administered with extreme caution, with the following drugs.

−    Medications that may induce hepatic monooxygenase, such as rifampicin, cimetidine, ranitidine and antiepileptic such as glutetimide, phenobarbital, carbamazepine;
−    Inhibitors of monoaminooxydase (IMAO), with an increase of the risk of grave hypertensive crises.

Use Fluimucil Influenza e Raffreddore under strict medical supervision if the following drugs are being taken:

−    Metildopa, with risk of reduction of the anti-hypertensive effect of the latter
−    Midodrina, with risk of increase of the hypertensive effect of the latter.

Due to the presence of pseudoephedrine, avoid associating with other sympathomimetics or guanethidine.

Fluimucil Influenza e Raffreddore may interfere with the following clinical tests:

−    determination of uric acid by means of the phosphotungstic acid method.

Fluimucil Influenza e Raffreddore is not advised in the following cases:

- Hypersensitivity to the active ingredients or any of the excipients
- Pregnancy and  breastfeeding
- Children below 12 years of age
- Patients with manifest insufficiency f glucose-6-phosphate dehydrogenase
- Parties affected by a grave form of the following diseases:
        - coronary disease (angina, preceding infarct);
        - hypertension; 
        - arrhythmia;
        - hepatic insufficiency;
        - renal block;
        - hyperthyroidism;
        - asthma;
        - diabetes;
        - disorders of urination caused by prostatic hypertrophy and other pathologies;
        - glaucoma;
        - haemolytic anaemia.
- Parties who are in treatment with inhibitors of monoamine oxidase or who have interrupted this treatment for less than two weeks;
- Parties subject to phenylketonuria.

Fluimucil Influenza e Raffreddore is to be administered only under strict medical supervision in cases of light or moderate forms of the following diseases:

- coronary disease (angina, preceding infarct);

- hypertension;

- arrhythmia;

- hepatic insufficiency;

- renal block;    

- hyperthyroidism;

- asthma;

- diabetes;

- disorders of urination caused by prostatic hypertrophy and other pathologies;     

- glaucoma;

- haemolytic anaemia.


Do not take Fluimucil Influenza e Raffreddore associated with other analgesic antipyretics or other drugs containing Paracetamol; do not prolong the therapy for more than three consecutive days without consulting family doctor.

Source: AIFA

 

 

 

Nota: vi rendiamo attenti sul fatto che state per lasciare il sito www.fluimucil.ch. Zambon Svizzera SA non ha alcuna influenza sui contenuti e sul concetto delle pagine linkate e declina quindi ogni responsabilità.

continua